A fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt
en-GBde-DEes-ESfr-FR

A fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt

04.09.2026 TranSpread

This study was led by Tao Dong at the Department of Immunology and Microbiology, School of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, with collaborators from several institutions. Pseudomonas aeruginosa is a major hospital-associated pathogen whose type VI secretion systems (T6SSs) mediate competition and interactions with host cells. Most reference strains encode three T6SSs, H1-H3, but comparative genomics has identified an additional H4-T6SS in a subset of clinical isolates. Whether this accessory system is functional, how it is activated, and what toxins it deploys were unresolved.

Using the clinical isolate LYSZa7, the researchers found that the native H4-T6SS is transcriptionally silent under the tested laboratory conditions. They therefore rewired its promoters to test the latent capacity of the locus. Upon activation, H4-T6SS assembled dynamic sheaths, secreted Hcp4, and mediated strong antibacterial activity against Escherichia coli, Vibrio cholerae, and P. aeruginosa. The activated system also caused cytotoxicity toward murine macrophage cells, demonstrating that H4 encodes a complete and functional secretion apparatus when expressed.

Secretome analysis and genetic screening identified TseMt as a major H4-associated antibacterial effector. Deleting tseMt abolished H4-dependent killing of V. cholerae, while the cognate immunity protein TsiMt protected target cells. TseMt acts in the periplasm, binds membranes, and forms ion-conducting pores in lipid bilayers. A 3.0-Å single-particle cryo-EM structure revealed a compact three-domain architecture consisting of an N-terminal MIX-like domain, a central alpha-helical scaffold, and a C-terminal colicin-like toxin domain. Membrane-interacting elements are buried in the soluble structure, supporting a model in which a conformational rearrangement exposes them for membrane insertion and pore formation.

Genetic analysis further showed that TseMt activity depends on a dedicated DUF4123 chaperone, VgrG4b, and PAAR4. Structural modeling supports a PAAR4-VgrG4b-chaperone-TseMt delivery complex. The study therefore provides the first functional validation of a P. aeruginosa H4-T6SS and the first mechanistic characterization of an H4-encoded effector. It also raises an important next question: which clinical, host-associated, or polymicrobial signals naturally activate this otherwise silent competitive module?

###

References

DOI

10.1002/mlf2.70108

Original Source URL

https://doi.org/10.1002/mlf2.70108

Funding information

This work was supported by funding from Shenzhen Medical Research Fund (B2402028), National Natural Science Foundation of China (W2431022, 32530004, W2433062, and 32400096), the Guangdong Innovative and Entrepreneurial Research Team Program (2023ZT10Y013), Guangdong Basic and Applied Basic Research Foundation (2024A1515010319), Science and Technology Program of Shenzhen (KCXFZ20230731100901003), and Shenzhen Key Laboratory of Biochip (grant No. SYSPG20241211173949065).

About mLife

mLife is an open access microbiology journal, sponsored by the Institute of Microbiology of the Chinese Academy of Sciences, in cooperation with the Chinese Society for Microbiology. The journal aims to publish novel and high-impact discoveries in a wide spectrum of disciplines in microbiology. mLife has been indexed by ESCI, PubMed, Scopus, DOAJ, CSCD, CAS, Google Scholar, etc. The 2025 Journal Citation Reports impact factor (released in 2026) is 6.7 (Q1/Microbiology).

Paper title: Functional characterization of a pore-forming effector TseMt from the H4 type VI secretion system of Pseudomonas aeruginosa
Angehängte Dokumente
  • Model of H4-T6SS-mediated TseMt delivery and function in clinical Pseudomonas aeruginosa LYSZa7
04.09.2026 TranSpread
Regions: North America, United States
Keywords: Science, Life Sciences, Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement